Leukemia Clinical Trials

Showing 441-460 of 9,450 trials

PIM Incidence in Older Cardiovascular Patients During COVID-19 Pandemics

NCT05336565

The aim of the study is to assess the incidence of potentially inappropriate medication (PIM) administration, polypharmacy, and potential drug-drug-interactions (PDDIs) in cardiovascular patients enrolled in the reimbursement program in the time of coronavirus disease (COVID-19) pandemic. Medical information system (MIS) "BARS" will be used for inclusion and retrieval of relevant data of cardiovascular patients enrolled in the reimbursement programs in the Tomsk Region. The incidence rates of PIM prescriptions will be assessed in patients aged 75 years and older. Potentially inappropriate medications will be defined according to 2015 Beers criteria. Polypharmacy will be defined as being administered five or more medications at the same time. PDDIs will be checked with Medscape Drug Interaction Checker and rated as 'Contraindicated', 'Serious', and 'Requiring Monitoring'. Combined analysis of retrospective and prospective occurrences of study parameters will be performed. PIM-BARS will evaluate the incidence rates and patterns of PIM prescriptions, polypharmacy, and PDDIs in elderly cardiovascular patients enrolled in the reimbursement program in the time of COVID-19 pandemic.

Potentially Inappropriate Medications

Tomsk National Research Medical Center of the Russian Academy of Sciences1,000 participantsStarted Jul 2022

Tomsk, Russia

RECRUITING

Association Between Intake of Psychotropic Medications and Risk of Falls in Older Adults

NCT07112573

The aim of the study is to assess the association between intake of psychotropic medications and increased risk of falls in older adults discharged from Ain Shams University Geriatric Hospital as a primary outcome and incident fractures that may occur as a secondary outcome of such fall.

Falls (Accidents) in Old AgePsychotropic Drugs

Ain Shams University398 participantsStarted Jul 2025

Cairo, Abbassia, Egypt

Active Not RecruitingNA

Improving Medical Decision Making for Older Patients With End Stage Renal Disease

NCT04347629

The overall objective of this study is to reduce the burden of chronic kidney disease (CKD) and its consequences for an aging U.S. population. To accomplish this, the investigators propose to conduct a multi-center randomized trial of an advance care planning (ACP) video intervention (vs. usual care) among older patients with CKD.

Renal Disease, End StagePalliative CareDecision Aids

Tufts Medical Center456 participantsStarted Jun 2021

Palo Alto, California, United States • Palo Alto, California, United States • Boston, Massachusetts, United States +6 more locations

PIM Incidence in Older Cardiovascular Patients During COVID-19 Pandemics

Association Between Intake of Psychotropic Medications and Risk of Falls in Older Adults

Improving Medical Decision Making for Older Patients With End Stage Renal Disease

Related Searches

Understanding Allergies and Sensitizations in Healthy and Allergic Individuals

Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD Tailored Treatment for Young Patients With High-risk CLL

Evaluating the Efficacy of Suture Mesh vs. Planar Mesh in Ventral Hernia Treatment

A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Different Administration Regimens of CAZ-AVI in Combination With ATM for the Treatment of CR-GNB

Early Clinical Study on the Use of Donor-derived EBV-specific T Cells for the Prevention of EBV Infection After Allogeneic Hematopoietic Stem Cell Transplantation

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance

Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias